Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Natale Cascinelli

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|May 17, 2003
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanomaRoberta Mortarini, Adriano Piris, Andrea Maurichi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanomaMassimo Di Nicola, Carmelo Carlo-Stella, Roberta Mortarini, et al.
Human Gene Therapy|September 25, 2003
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trialMassimo Di Nicola, Carmelo Carlo-Stella, Andrea Anichini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastasesCharles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging databaseJohn F Thompson, Seng-Jaw Soong, Charles M Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findingsFiliberto Belli, Alessandro Testori, Licia Rivoltini, et al.
Journal of Translational Medicine|June 5, 2013
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"Paolo A Ascierto, Antonio M Grimaldi, Nicolas Acquavella, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Cancer Research|May 17, 2003
Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanomaRoberta Mortarini, Adriano Piris, Andrea Maurichi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 2004
Boosting T cell-mediated immunity to tyrosinase by vaccinia virus-transduced, CD34(+)-derived dendritic cell vaccination: a phase I trial in metastatic melanomaMassimo Di Nicola, Carmelo Carlo-Stella, Roberta Mortarini, et al.
Human Gene Therapy|September 25, 2003
Clinical protocol. Immunization of patients with malignant melanoma with autologous CD34(+) cell-derived dendritic cells transduced ex vivo with a recombinant replication-deficient vaccinia vector encoding the human tyrosinase gene: a phase I trialMassimo Di Nicola, Carmelo Carlo-Stella, Andrea Anichini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 7, 2010
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastasesCharles M Balch, Jeffrey E Gershenwald, Seng-Jaw Soong, et al.
Seminars in Surgical Oncology|August 19, 2003
New TNM melanoma staging system: linking biology and natural history to clinical outcomesCharles M Balch, Antonio C Buzaid, Seng-Jaw Soong, et al.
CA: a Cancer Journal for Clinicians|June 16, 2004
An evidence-based staging system for cutaneous melanomaCharles M Balch, Seng-Jaw Soong, Michael B Atkins, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging databaseJohn F Thompson, Seng-Jaw Soong, Charles M Balch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findingsFiliberto Belli, Alessandro Testori, Licia Rivoltini, et al.
Journal of Translational Medicine|June 5, 2013
Future perspectives in melanoma research. Meeting report from the "Melanoma Bridge. Napoli, December 2nd-4th 2012"Paolo A Ascierto, Antonio M Grimaldi, Nicolas Acquavella, et al.
Pageof 2